BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11267530)

  • 21. Controlling the incidence of infection and malignancy by modifying immunosuppression.
    Soulillou JP; Giral M
    Transplantation; 2001 Dec; 72(12 Suppl):S89-93. PubMed ID: 11833147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal cell carcinoma in the native and allograft kidneys of renal transplant recipients.
    Leveridge M; Musquera M; Evans A; Cardella C; Pei Y; Jewett M; Robinette M; Finelli A
    J Urol; 2011 Jul; 186(1):219-23. PubMed ID: 21575970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignancy after renal transplantation.
    Zeier M; Hartschuh W; Wiesel M; Lehnert T; Ritz E
    Am J Kidney Dis; 2002 Jan; 39(1):E5. PubMed ID: 11774131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solid Organ Cancer and Melanoma in Kidney Transplant Recipients: TumorTx Base Preliminary Results.
    Lizakowski S; Kolonko A; Imko-Walczuk B; Komorowska-Jagielska K; Rutkowski B; Więcek A; Dębska-Ślizień A
    Transplant Proc; 2018; 50(6):1881-1888. PubMed ID: 30056921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late development of renal carcinoma in allograft kidney.
    Feldman JD; Jacobs SC
    J Urol; 1992 Aug; 148(2 Pt 1):395-7. PubMed ID: 1635145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal cell carcinomas of donor origin in two kidney transplants from a single donor.
    Heinz-Peer G; Helbich T; Barnas U; Mayer G; Mühlbacher F; Mostbeck GH
    Transplantation; 1995 Mar; 59(6):912-3. PubMed ID: 7701592
    [No Abstract]   [Full Text] [Related]  

  • 27. The transmission of donor-derived malignant melanoma to a renal allograft recipient.
    Milton CA; Barbara J; Cooper J; Rao M; Russell C; Russ G
    Clin Transplant; 2006; 20(5):547-50. PubMed ID: 16968479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. De novo renal cell carcinoma in a kidney allograft 13 years after transplantation: a case report and review of the literature.
    Zavos G; Kakisis J; Bokos J; Pappas P; Boletis J; Kostakis A
    Urol Int; 2007; 78(3):283-5. PubMed ID: 17406143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Partial nephrectomy used to treat renal cell carcinoma arising in a live donor transplant kidney.
    Lamb GW; Baxter GM; Rodger RS; Aitchison M
    Urol Res; 2004 May; 32(2):89-92. PubMed ID: 15250100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Donor origin of neuroendocrine carcinoma in 2 transplant patients determined by molecular cytogenetics.
    Baehner R; Magrane G; Balassanian R; Chang C; Millward C; Wakil AE; Osorio RW; Waldman FM
    Hum Pathol; 2000 Nov; 31(11):1425-9. PubMed ID: 11112220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central nervous system tumors in donors: misdiagnosis carries a high morbidity and mortality.
    Buell JF; Gross T; Alloway RR; Trofe J; Woodle ES
    Transplant Proc; 2005 Mar; 37(2):583-4. PubMed ID: 15848464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-transplant de novo malignancies in renal transplant recipients: the past and present.
    Kauffman HM; Cherikh WS; McBride MA; Cheng Y; Hanto DW
    Transpl Int; 2006 Aug; 19(8):607-20. PubMed ID: 16827677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of solid tumours in organ-transplant recipients.
    Ajithkumar TV; Parkinson CA; Butler A; Hatcher HM
    Lancet Oncol; 2007 Oct; 8(10):921-32. PubMed ID: 17913661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metastatic malignant melanoma transplanted via a renal homograft: a case report.
    Peters MS; Stuard ID
    Cancer; 1978 Jun; 41(6):2426-30. PubMed ID: 350378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dermatopathology of skin cancer in solid organ transplant recipients.
    Stoff B; Salisbury C; Parker D; O'Reilly Zwald F
    Transplant Rev (Orlando); 2010 Oct; 24(4):172-89. PubMed ID: 20709518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant melanoma in solid transplant recipients: collection of database cases and comparison with surveillance, epidemiology, and end results data for outcome analysis.
    Brewer JD; Christenson LJ; Weaver AL; Dapprich DC; Weenig RH; Lim KK; Walsh JS; Otley CC; Cherikh W; Buell JF; Woodle ES; Arpey C; Patton PR
    Arch Dermatol; 2011 Jul; 147(7):790-6. PubMed ID: 21768478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal cell carcinoma of the native kidney: a frequent tumor after kidney transplantation with favorable prognosis in case of early diagnosis.
    Végsö G; Toronyi E; Hajdu M; Piros L; Görög D; Deák PA; Doros A; Péter A; Langer RM
    Transplant Proc; 2011 May; 43(4):1261-3. PubMed ID: 21620106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Posttransplant Malignancy.
    Rossi AP; Klein CL
    Surg Clin North Am; 2019 Feb; 99(1):49-64. PubMed ID: 30471741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk for tumor and other disease transmission by transplantation: a population-based study of unrecognized malignancies and other diseases in organ donors.
    Birkeland SA; Storm HH
    Transplantation; 2002 Nov; 74(10):1409-13. PubMed ID: 12451241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-post-transplant lymphoproliferative disorder cancers in children after organ transplantation.
    Dharnidharka VR; Kulsum-Mecci N
    Pediatr Transplant; 2013 Dec; 17(8):707-9. PubMed ID: 24118973
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.